Main

Developing small molecules for respiratory and inflammatory diseases

Treamid Therapeutics GmbH

Robert-Rössle-Str. 10

Haus 80 (Otto-Warburg-Haus)

13125 Berlin

Contact:
Disclamer

This website provides general information about our company, its products and services. Due to the nature of our products and services they may be subject to change and some of them are provided only regionally or with a regional difference as reflected by their customized nature. Our webpage and its contents do not purport to convey medical advice, and on no account is it a substitute for a consultation with a medical practitioner. The attention of users of our products is drawn to the directions for use accompanying the product. All content is prepared with the greatest possible care and is subject to constant updates and additions. We accept no liability for any errors arising, nor for the continuing relevance of the content to the current situation. We accept no liability for third-party content quoted by us on this website or to which we refer through hyperlinks. The content of this website is intended for users within the European Union and has been prepared by us under the provisions of German law. We do not guarantee the legality of this website under the jurisdiction of other countries. All copyright for the content of this website is vested in our company. The application of this material for commercial purposes is permitted only with our prior authorization

Read more →
Disclamer

This website provides general information about our company, its products and services. Due to the nature of our products and services they may be subject to change and some of them are provided only regionally or with a regional difference as reflected by their customized nature. Our webpage and its contents do not purport to convey medical advice, and on no account is it a substitute for a consultation with a medical practitioner. The attention of users of our products is drawn to the directions for use accompanying the product. All content is prepared with the greatest possible care and is subject to constant updates and additions. We accept no liability for any errors arising, nor for the continuing relevance of the content to the current situation. We accept no liability for third-party content quoted by us on this website or to which we refer through hyperlinks. The content of this website is intended for users within the European Union and has been prepared by us under the provisions of German law. We do not guarantee the legality of this website under the jurisdiction of other countries. All copyright for the content of this website is vested in our company. The application of this material for commercial purposes is permitted only with our prior authorization

Company overview

Treamid Therapeutics GmbH was founded in 2016 with the aim to develop new and innovative treatments for respiratory and inflammatory diseases. All our small molecules are under global patent protection.

Our aim is to develop new drugs in the area of high unmet need for respiratory and inflammatory disease, supporting patients with new innovative and easily accessible medications.

We are collaborating with well-renowned institutions and CROs in different fields of our research and development. We also have our own in vitro lab driving our research and developing new methods to further investigate our molecules in different disease areas.

Pipeline

Pipeline
  • Candidate
  • Indication
  • IP
  • Stage
  • T01
  • Long-COVID
    COPD
    Fibrosis
  • Global rights
  • Phase II
    Pre-clinical
    Pre-clinical
  • T02
  • Pain
    Cough
  • Global rights
  • Phase Ia
    Pre-clinical
  • T03
  • Idiopathic pulmonary fibrosis
    COPD
    Fibrosis
  • Global rights
  • Phase Ia
    Pre-clinical
    Pre-clinical